Norman Swan

speaker
10,140 appearances 108 recordings 1 series first heard Mar 2020 last heard 11 Aug

Norman Swan’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Aug OctJan 26AprJulnow

Recordings per month over the last 12 months — 2 in all, peaking in Aug 2026 with 1.

Appearances

newest first · ▶ plays the moment
We've just got to see whether or not it works with SARS-CoV-2.
They do have side effects, by the way, with HIV.
So this one would have to, you know, the side effect profile would have to be pretty closely monitored.
They can be quite expensive drugs.
So that's the other side of this is what the cost would be.
But this would be treatment for people who have got COVID-19, presumably high risk people.
And it would stop the virus replicating and presumably stop infection of others, which in fact is what happens with HIV.
When you get the HIV viral load down very, very low, you actually can prevent transmission.
Yeah.
So this, even if they accelerate, they will get a lot of patients, unfortunately, because there's still a lot of COVID around.
So it's going to be quite easy to do.
a phase three trial if it's safe in phase one.
So phase one is gross safety.
So they will be able to recruit a lot of patients quite quickly in the same way as they were for the vaccines.
So it'll be a great thing because we are short of antiviral drugs.
So it'll be a fantastic thing to get.
And it's particularly in a world where the world is not going to be vaccinated to a significant extent anytime soon.
So a treatment is still going to be incredibly useful.
Who knows?
I mean, I think they're talking about moving into phase three trials quite quickly if the phase one is OK.
Showing 441–460 of 10,140 · page 23 of 507 ← Previous Next →